Investigating how lipid antigens contribute to inflammation in Type 2 Diabetes
Lipid Antigen Presentation as a Driver of T2D Inflammation
This study is looking at how certain fats in the body might cause inflammation that makes it harder for people with Type 2 Diabetes to use insulin properly, and it aims to find new ways to help manage this inflammation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10891636 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of lipid antigens in the chronic inflammation associated with Type 2 Diabetes (T2D). By using transgenic mice that express human CD1 molecules, the study aims to explore how these lipid antigens trigger immune responses that may lead to insulin resistance. The researchers will also utilize in vitro models to further investigate the immune mechanisms involved. The ultimate goal is to uncover new therapeutic targets for managing inflammation in T2D.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes who exhibit signs of chronic inflammation.
Not a fit: Patients without Type 2 Diabetes or those who do not show inflammatory responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel anti-inflammatory treatments for Type 2 Diabetes.
How similar studies have performed: While there has been significant research on inflammation in T2D, the exploration of lipid antigens is a novel approach that has not been extensively tested.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Nicholas, Dequina Angelina — University of California-Irvine
- Study coordinator: Nicholas, Dequina Angelina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.